Details:

Alternative Title:
Emerg Infect Dis
Publisher's site:
http://dx.doi.org/10.3201/eid0909.020666
Personal Author:
Bishara, Jihad ; Pitlik, Silvio ; Samra, Zmira ; Levy, Itzhak ; Paul, Mical ; ... More +
Bishara, Jihad ; Pitlik, Silvio ; Samra, Zmira ; Levy, Itzhak ; Paul, Mical ; Leibovici, Leonard Less -
Description:
Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.
Subjects:
[+]
Adult Anti-Bacterial Agents Co-Trimoxazole Cross Infection Dispatch Humans Israel Methicillin Methicillin Resistance Microbial Sensitivity Tests Nosocomial Resistance Staphylococcal Infections Staphylococcus Aureus Susceptibility Trimethoprim-Sulfamethoxazole Combination
Source:
Emerg Infect Dis. 9(9):1168-1169.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:0926a4a0c08172143ac595508b96345db0014438f8ed7fc9abce6e617af4a6f7
Download URL:
https://stacks.cdc.gov/view/cdc/14150/cdc_14150_DS1.pdf
File Type:

Supporting Files

• 	02-0666-F.gif	gif
  	02-0666-F.jpg	jpeg
  	02-0666.nxml	txt
  	license.txt	txt

More +